In this study, we first demonstrated the independent prognostic relevance of tumor-GSK3β activity as detected by the increased level of pGSK3βY216 that inversely associated with survival of GBM patients, while no correlation was found between the expression level of mRNA and total protein and the prognosis (data not shown). This evidence concerns the gene GSK3B and glioblastoma.